<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T07:20:21Z</responseDate>
  <request identifier="oai:figshare.com:article/33810917" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33810917</identifier>
        <datestamp>2026-09-15T17:34:41Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Patient-level major adverse cardiovascular events in the study population, by management fee period.&lt;/p&gt;</dc:title>
          <dc:creator>Satoshi Yamasaki (11582)</dc:creator>
          <dc:creator>Tomotake Tokunou (752598)</dc:creator>
          <dc:creator>Takahiko Horiuchi (186336)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>nationwide claims database</dc:subject>
          <dc:subject>key risk factor</dc:subject>
          <dc:subject>insurance system aimed</dc:subject>
          <dc:subject>frequent combination therapy</dc:subject>
          <dc:subject>developing treatment plans</dc:subject>
          <dc:subject>approximately 6 months</dc:subject>
          <dc:subject>cardiovascular event rates</dc:subject>
          <dc:subject>specific management fee</dc:subject>
          <dc:subject>identify patient groups</dc:subject>
          <dc:subject>better patient involvement</dc:subject>
          <dc:subject>nationwide study using</dc:subject>
          <dc:subject>compare lipid control</dc:subject>
          <dc:subject>010 outpatient visits</dc:subject>
          <dc:subject>years ); therefore</dc:subject>
          <dc:subject>xlink "&gt; dyslipidemia</dc:subject>
          <dc:subject>national fee revision</dc:subject>
          <dc:subject>japan &amp;# 8217</dc:subject>
          <dc:subject>new fee structure</dc:subject>
          <dc:subject>real world patterns</dc:subject>
          <dc:subject>outpatient visits</dc:subject>
          <dc:subject>revision patient</dc:subject>
          <dc:subject>new fee</dc:subject>
          <dc:subject>world impact</dc:subject>
          <dc:subject>ourpatient visits</dc:subject>
          <dc:subject>cardiovascular disease</dc:subject>
          <dc:subject>previous fee</dc:subject>
          <dc:subject>fee categories</dc:subject>
          <dc:subject>patient level</dc:subject>
          <dc:subject>800 patient</dc:subject>
          <dc:subject>primary prevention</dc:subject>
          <dc:subject>primary outcome</dc:subject>
          <dc:subject>previous disease</dc:subject>
          <dc:subject>prevalence continues</dc:subject>
          <dc:subject>population aging</dc:subject>
          <dc:subject>may benefit</dc:subject>
          <dc:subject>longer follow</dc:subject>
          <dc:subject>lipid parameters</dc:subject>
          <dc:subject>lipid levels</dc:subject>
          <dc:subject>less often</dc:subject>
          <dc:subject>international classification</dc:subject>
          <dc:subject>holistic approach</dc:subject>
          <dc:subject>complementary designs</dc:subject>
          <dc:subject>cause mortality</dc:subject>
          <dc:subject>causal impact</dc:subject>
          <dc:subject>category analyses</dc:subject>
          <dc:subject>cardiovascular outcomes</dc:subject>
          <dc:subject>cannot exclude</dc:subject>
          <dc:subject>based interventions</dc:subject>
          <dc:subject>also similar</dc:subject>
          <dc:description>&lt;p&gt;Patient-level major adverse cardiovascular events in the study population, by management fee period.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T17:34:35Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358270.t003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Patient-level_major_adverse_cardiovascular_events_in_the_study_population_by_management_fee_period_p_/33810917</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
